Splenic Infarcts and Pulmonary Emboli: The Thromboembolic Potential of Covid-19

Title: Splenic Infarcts and Pulmonary Emboli: The Thromboembolic Potential of Covid-19
Author(s): K. Elkholy, A. Antonenko, A. Gabr, N. McEvoy, D. O’Keeffe, M. O’Connor
Institution: University Hospital Limerick
Poster: Click to view poster
Category: COVID-19
Abstract: Incidence of thromboembolic disease is reported to be high in SARS-CoV2 disease and is seen in a multitude of organ systems ranging from cutaneous thrombosis to pulmonary embolism, stroke or coronary thrombosis sometimes with catastrophic outcomes.

Evidence points towards a key role of thromboembolism, hypercoagulability and over production of proinflammatory cytokines mimicking a “cytokine storm” which leads to multiorgan failure. [1]
]

Here, we report a case of pulmonary Covid-19 infection with acute splenic infarcts and pulmonary emboli. We believe this is potentially among the first published cases to include contrast-enhanced imaging of splenic infarcts in this condition. There is a growing body of published evidence that complications of Covid-19 are not limited to the pulmonary system. [2] To our knowledge, this is the first reported clinical image case of Covid-19-related splenic infarcts.